Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

Oncogene

Volumn 28, Issue 20, 2009, Pages 2119-2123

  Jones, D T W ^a   Kocialkowski, S ^a   Liu, L ^a   Pearson, D M ^a   Ichimura, K ^a   Collins, V P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BRAF; Fusion gene, pilocytic astrocytoma; MAPK; RAF1; SRGAP3

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

ARTICLE; ASTROCYTOMA; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE FUSION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ASTROCYTOMA; COMPARATIVE GENOMIC HYBRIDIZATION; GENE REARRANGEMENT; GTPASE-ACTIVATING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MUTATION; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 67349219657     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.73     Document Type: Article

References (26)

1. Bonner T, O'Brien SJ, Nash WG, Rapp UR, Morton CC, Leder P. (1984). The human homologs of the raf (mil) oncogene are located on human chromosomes 3 and 4. Science 223: 71 - 74.
2. Central Brain Tumour Registry of the United States (2005). Statistical Report: Primary Brain Tumours in the United States, 1997-2001. CBTRUS: Chicago, IL.
3. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
4. Dirven CM, Mooij JJ, Molenaar WM. (1997). Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 13: 17-23.
5. Emuss V, Garnett M, Mason C, Marais R. (2005). Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF. Cancer Res 65: 9719-9726.
6. Endris V, Wogatzky B, Leimer U, Bartsch D, Zatyka M, Latif F et al. (2002). The novel Rho-GTPase activating gene MEGAP/srGAP3 has a putative role in severe mental retardation. Proc Natl Acad Sci USA 99: 11754-11759.
7. Giannini C, Scheithauer BW. (1997). Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 7: 785-798.
8. Icking A, Schilling K, Wiesenthal A, Opitz N, Muller-Esterl W. (2006). FCH/Cdc15 domain determines distinct subcellular localization of NOSTRIN. FEBS Lett 580: 223-228.
9. Janzarik WG, Kratz CP, Loges NT, Olbrich H, Klein C, Schafer T et al. (2007). Further Evidence for a Somatic KRAS Mutation in a Pilocytic Astrocytoma. Neuropediatrics 38: 61-63.
10. Jones DTW, Ichimura K, Liu L, Pearson DM, Plant K, Collins VP. (2006). Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J Neuropathol Exp Neurol 65: 1049-1058.
11. Jones DTW, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K et al. (2008). Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68: 8673 - 8677.
12. Le LQ, Parada LF. (2007). Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 26: 4609-4616.
13. Listernick R, Charrow J, Gutmann DH. (1999). Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89: 38-44.
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. (2007). WHO Classification of Tumours of the Central Nervous System. IARC Press: Lyon, France, 309 pp.
15. Maltzman TH, Mueller BA, Schroeder J, Rutledge JC, Patterson K, Preston-Martin S et al. (1997). Ras oncogene mutations in childhood brain tumors. Cancer Epidemiol Biomarkers Prev 6: 239-243.
16. Moretti S, Macchiarulo A, De Falco V, Avenia N, Barbi F, Carta C et al. (2006). Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene 25: 4235-4240.
17. Office for National Statistics (2004). The Health of Children and Young People. Office for National Statistics: UK.
18. Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds Jr FH et al. (1983). Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus. Proc Natl Acad Sci USA 80: 4218-4222.
19. Sharma MK, Zehnbauer BA, Watson MA, Gutmann DH. (2005). RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma. Neurology 65: 1335-1336.
20. Shimizu K, Nakatsu Y, Nomoto S, Sekiguchi M. (1986). Structure of the activated c-raf-1 gene from human stomach cancer. Princess Takamatsu Symp 17: 85-91.
21. Soderling SH, Guire ES, Kaech S, White J, Zhang F, Schutz K et al. (2007). A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci 27: 355-365.
22. Stanton Jr VP, Nichols DW, Laudano AP, Cooper GM. (1989). Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol Cell Biol 9: 639-647.
23. Tahira T, Ochiai M, Hayashi K, Nagao M, Sugimura T. (1987). Activation of human c-raf-1 by replacing the N-terminal region with different sequences. Nucleic Acids Res 15: 4809-4820.
24. Tomlinson FH, Scheithauer BW, Hayostek CJ, Parisi JE, Meyer FB, Shaw EG et al. (1994). The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study. J Child Neurol 9: 301-310.
25. Yang Y, Marcello M, Endris V, Saffrich R, Fischer R, Trendelenburg MF et al. (2006). MEGAP impedes cell migration via regulating actin and micro tubule dynamics and focal complex formation. Exp Cell Res 312: 2379-2393.
26. Zebisch A, Troppmair J. (2006). Back to the roots: the remarkable RAF oncogene story. Cell Mol Life Sci 63: 1314-1330.